<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35428433</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1558-318X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>49</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
            </PubDate>
          </JournalIssue>
          <Title>The Urologic clinics of North America</Title>
          <ISOAbbreviation>Urol Clin North Am</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pharmacologic Management of Interstitial Cystitis/Bladder Pain Syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>273</StartPage>
          <EndPage>282</EndPage>
          <MedlinePgn>273-282</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ucl.2022.01.003</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0094-0143(22)00003-9</ELocationID>
        <Abstract>
          <AbstractText>Interstitial cystitis/bladder pain syndrome (IC/BPS) is defined as persistent or chronic discomfort perceived to be related to the urinary bladder accompanied by urinary urgency or frequency. Pharmacotherapies used to treat IC/BPS include oral and intravesical agents. Oral therapies include amitriptyline, hydroxyzine, cyclosporine A, and pentosan polysulfate sodium (PPS), although the recent finding of pigmented maculopathy with chronic PPS is very concerning and must be discussed with patients, many of whom will choose to either come off this medicine or not even start it. Certolizumab pegol is a pharmacologic therapy that is currently in clinical development for treatment of IC/BPS symptoms.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chermansky</LastName>
            <ForeName>Christopher J</ForeName>
            <Initials>CJ</Initials>
            <AffiliationInfo>
              <Affiliation>Chief of Urology UPMC Magee Womens Hospital, 300 Halket Street, Suite 2541, Pittsburgh, PA 15213, USA. Electronic address: chermanskycj2@upmc.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guirguis</LastName>
            <ForeName>Marina O</ForeName>
            <Initials>MO</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Urogynecology, Department of Obstetrics and Gynecology, Magee Womens Hospital, 300 Halket Street, Pittsburgh, PA 15213, USA. Electronic address: https://twitter.com/@MGuirguisMD.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Urol Clin North Am</MedlineTA>
        <NlmUniqueID>0423221</NlmUniqueID>
        <ISSNLinking>0094-0143</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>37300-21-3</RegistryNumber>
          <NameOfSubstance UI="D010426">Pentosan Sulfuric Polyester</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D018856" MajorTopicYN="Y">Cystitis, Interstitial</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010426" MajorTopicYN="N">Pentosan Sulfuric Polyester</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001743" MajorTopicYN="N">Urinary Bladder</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bladder pain syndrome</Keyword>
        <Keyword MajorTopicYN="N">Interstitial cystitis</Keyword>
        <Keyword MajorTopicYN="N">Intravesical treatment</Keyword>
        <Keyword MajorTopicYN="N">Pharmacology</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>16</Day>
          <Hour>5</Hour>
          <Minute>17</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35428433</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ucl.2022.01.003</ArticleId>
        <ArticleId IdType="pii">S0094-0143(22)00003-9</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
